Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Filings indexed 708 across all filing types
Latest filing 2020-08-18 Regulatory Filings
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Expanded Partnership with LG Chem Life Sciences
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 3640W' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates a regulatory news service announcement. The content details an expansion of a partnership and associated financial milestones, which is a material event announcement. Since it is a general regulatory announcement disseminated via RNS and does not fit the specific criteria for Earnings Release (ER), Director's Dealing (DIRS), or Capital Change (CAP), the most appropriate classification is the general Regulatory Filings category (RNS). The document length (7580 chars) is substantial enough that it is not merely an announcement of a report (RPA), but the report itself (the news release).
2020-08-18 English
Clarification Regarding Medusa 19 Antibody Test
Legal Proceedings Report Classification · 99% confidence The document begins with an 'RNS Number' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' This strongly indicates a regulatory news service announcement. The content itself is a clarification regarding a product (antibody test) and mentions updating the market when appropriate, which is typical for a general regulatory disclosure that doesn't fit a more specific category like Director's Dealing (DIRS), Dividend (DIV), or Earnings Release (ER). Since RNS is the designated category for general regulatory announcements not covered elsewhere, RNS is the most appropriate classification.
2020-08-17 English
Holding(s) in Company
Major Shareholding Notification Classification · 98% confidence The document explicitly starts with 'RNS Number : 7832V' and contains the header 'TR-1: Standard form for notification of major holdings'. This form is used to report changes in significant share ownership, which corresponds to the definition of Major Shareholding Notification (MRQ). However, the document is distributed via RNS, the news service of the London Stock Exchange, and the content is a regulatory disclosure about shareholding changes. Since 'Major Shareholding Notification' (MRQ) is a specific category for changes in significant share ownership, it is the most precise fit. The presence of the RNS header and the nature of the filing (TR-1) confirms it is a regulatory disclosure, but MRQ is more specific than the general RNS fallback.
2020-08-11 English
Therapeutics Chief Development Officer Appointment
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated '11 August 2020'. The content announces the appointment of a new executive, Neil Bell, as Chief Development Officer. This type of announcement, concerning changes in senior management, directly corresponds to the definition of Board/Management Information (MANG). Although it is distributed via RNS (Regulatory News Service), the core subject matter is management change, making MANG the most specific classification. The document length is substantial (8694 chars), so it is not a simple RPA or RNS fallback unless no other category fits.
2020-08-11 English
SARS-CoV-2 Antigen Test Clinical Collaboration
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 4398V' and is dated '07 August 2020'. The content is an announcement regarding a clinical collaboration for a SARS-CoV-2 rapid antigen test. The structure, including the RNS header and the nature of the announcement (a business update/collaboration), strongly indicates it is a regulatory news service release from the London Stock Exchange. This fits the definition of a general regulatory announcement that doesn't fit a more specific financial report category. Therefore, the appropriate code is RNS.
2020-08-07 English
COVID-19 Rapid Antigen Test Manufacturing Partner
Regulatory Filings Classification · 100% confidence The document begins with 'RNS Number : 2934V' and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS (Regulatory News Service) filings are used for immediate public disclosure of material information, often covering operational updates, partnerships, or significant announcements that are not standard periodic reports (like 10-K or IR). The content details a new manufacturing partnership for a COVID-19 test, which is a significant operational announcement. Since this is a direct, immediate announcement via the RNS system and not a formal periodic report or a simple announcement of a report's publication, the most appropriate classification is the general regulatory announcement category.
2020-08-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.